Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Etravirine with TDF/FTC +/- Darunavir/Ritonavir in HIV-1
NCT00534352Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Jan 2008
- Primary completion
- May 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of etravirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Johnson & Johnson. Started Jan 2008; status: completed.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00534352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534352.